National Research Corp Reports Significant Q4 and Full-Year 2025 Profitability Declines
summarizeSummary
National Research Corporation announced its Q4 and full-year 2025 financial results, reporting significant year-over-year declines in GAAP revenue, net income, and diluted EPS, despite growth in TRCV and Q4 operating cash flow.
check_boxKey Events
-
Q4 2025 GAAP Profitability Declines
Fourth quarter 2025 GAAP net income fell 72.6% year-over-year to $1.8 million, with diluted EPS dropping 71.4% to $0.08. Revenue also decreased 4.6% year-over-year to $35.2 million.
-
Full-Year 2025 GAAP Results Show Significant Drop
For the full year 2025, GAAP net income decreased 53.2% to $11.6 million, and diluted EPS declined 51.9% to $0.50. Total revenue for the year was $137.4 million, a 4.0% decrease from 2024.
-
Positive Operational Metrics
Despite profitability declines, the company reported a 13% year-over-year increase in Q4 2025 cash flow from operations to $7.2 million and an 8% year-over-year growth in Total Recurring Contract Value (TRCV) to $144.1 million.
-
Quarterly Cash Dividend Declared
The Board of Directors declared a quarterly cash dividend of $0.16 per share, payable on April 10, 2026, to shareholders of record as of March 27, 2026.
auto_awesomeAnalysis
National Research Corporation's fourth quarter and full-year 2025 results show substantial year-over-year declines in key GAAP profitability metrics, including revenue, net income, and diluted earnings per share. While the company highlighted positive growth in Total Recurring Contract Value (TRCV) and fourth-quarter cash flow from operations, the significant drop in core financial performance indicates operational challenges or increased costs. Investors will likely focus on the underlying reasons for these declines and the company's strategy to reverse the trend, especially given the competitive landscape in healthcare experience solutions. The routine dividend declaration provides some stability but does not offset the negative financial performance.
At the time of this filing, NRC was trading at $21.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $496.2M. The 52-week trading range was $9.76 to $22.79. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.